Isoprenaline

Generic Name
Isoprenaline
Brand Names
Isuprel
Drug Type
Small Molecule
Chemical Formula
C11H17NO3
CAS Number
7683-59-2
Unique Ingredient Identifier
L628TT009W
Background

Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock.
...

Indication

Isoprenaline is indicated to treat mild or transient episodes of heart block not requiring electric shock or pacemakers, serious episodes of heart block and Adams-Stokes attacks not caused by ventricular tachycardia or fibrillation, and bronchospasm during anesthesia. Isoprenaline is also indicated for cases of cardiac arrest until preferable treatments like...

Associated Conditions
Adams-Stokes attacks, Bradycardia, Bronchospasm, Cardiac Arrest, Cardiac electrical storm, Congestive Heart Failure (CHF), Hypoperfusion, Septic Shock, Serious Heart Block, Shock, Cardiogenic, Shock, Hypovolemic, Short QT syndrome, Syncope, Torsades de Pointes, Transient Heart Block, Ventricular Arrhythmia, Beta blocker overdose, Mild Heart Block
Associated Therapies
-

Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-06-21
Last Posted Date
2015-02-23
Lead Sponsor
NYU Langone Health
Target Recruit Count
20
Registration Number
NCT01377636
Locations
🇺🇸

NYU Langone Medical Center, Department of Anesthesiology, New York City, New York, United States

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract

First Posted Date
2007-01-30
Last Posted Date
2007-11-16
Lead Sponsor
Fredericia Hosptial
Target Recruit Count
12
Registration Number
NCT00428428
Locations
🇩🇰

Dp. of Urology, Fredericia & Kolding Hospitals, Fredericia, Denmark

Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone

Phase 2
Conditions
First Posted Date
2006-05-10
Last Posted Date
2007-01-30
Lead Sponsor
Fredericia Hosptial
Target Recruit Count
10
Registration Number
NCT00323843
Locations
🇩🇰

Dpt. of Urology, Fredericia, Vejle Council, Denmark

Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms

Not Applicable
Completed
Conditions
First Posted Date
2005-09-27
Last Posted Date
2008-10-29
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
100
Registration Number
NCT00226551
Locations
🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

© Copyright 2024. All Rights Reserved by MedPath